Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Surgery Partners (SGRY) Total Liabilities (2016 - 2025)

Historic Total Liabilities for Surgery Partners (SGRY) over the last 12 years, with Q3 2025 value amounting to $41.5 million.

  • Surgery Partners' Total Liabilities fell 2832.47% to $41.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $41.5 million, marking a year-over-year decrease of 2832.47%. This contributed to the annual value of $55.0 million for FY2024, which is 3349.51% up from last year.
  • Surgery Partners' Total Liabilities amounted to $41.5 million in Q3 2025, which was down 2832.47% from $40.6 million recorded in Q2 2025.
  • Over the past 5 years, Surgery Partners' Total Liabilities peaked at $57.9 million during Q3 2024, and registered a low of $19.1 million during Q3 2021.
  • Its 5-year average for Total Liabilities is $38.7 million, with a median of $41.2 million in 2023.
  • Per our database at Business Quant, Surgery Partners' Total Liabilities soared by 12110.55% in 2022 and then plummeted by 2832.47% in 2025.
  • Quarter analysis of 5 years shows Surgery Partners' Total Liabilities stood at $20.1 million in 2021, then soared by 103.48% to $40.9 million in 2022, then grew by 0.73% to $41.2 million in 2023, then skyrocketed by 33.5% to $55.0 million in 2024, then fell by 24.55% to $41.5 million in 2025.
  • Its Total Liabilities was $41.5 million in Q3 2025, compared to $40.6 million in Q2 2025 and $42.8 million in Q1 2025.